260
Views
16
CrossRef citations to date
0
Altmetric
Drug Profile

IXIARO® updated: overview of clinical trials and developments with the inactivated vaccine against Japanese encephalitis

Pages 859-869 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Christa Firbas & Bernd Jilma. (2015) Product review on the JE vaccine IXIARO. Human Vaccines & Immunotherapeutics 11:2, pages 411-420.
Read now
Tomohiro Ishikawa & Eiji Konishi. (2014) Japanese encephalitis: epidemiology, prevention and current status of antiviral drug development. Expert Opinion on Orphan Drugs 2:9, pages 923-936.
Read now

Articles from other publishers (14)

Kumar Saurabh Srivastava, Vandana Jeswani, Nabanita Pal, Babita Bohra, Vaishali Vishwakarma, Atharva Ashish Bapat, Yamini Prashanti Patnaik, Navin Khanna & Rahul Shukla. (2023) Japanese Encephalitis Virus: An Update on the Potential Antivirals and Vaccines. Vaccines 11:4, pages 742.
Crossref
Annaleise R. Howard-Jones, David Pham, Rebecca Sparks, Susan Maddocks, Dominic E. Dwyer, Jen Kok & Kerri Basile. (2023) Arthropod-Borne Flaviviruses in Pregnancy. Microorganisms 11:2, pages 433.
Crossref
Sanjay Kumar, Akanksha Verma, Pardeep Yadav, Sumit Kumar Dubey, Esam Ibraheem Azhar, S. S. Maitra & Vivek Dhar Dwivedi. (2022) Molecular pathogenesis of Japanese encephalitis and possible therapeutic strategies. Archives of Virology 167:9, pages 1739-1762.
Crossref
Carl R Alving. (2021) Walter Reed Army Institute of Research (WRAIR): Fifty Years of Achievements That Impact Science and Society. Military Medicine 186:3-4, pages 72-77.
Crossref
Stephen D. Carro & Sara Cherry. (2020) Beyond the Surface: Endocytosis of Mosquito-Borne Flaviviruses. Viruses 13:1, pages 13.
Crossref
Sheila M. Mackell & Mike Starr. 2019. Travel Medicine. Travel Medicine 125 136 .
Silvia Ratto-Kim, In-Kyu Yoon, Robert M. Paris, Jean-Louis Excler, Jerome H. Kim & Robert J. O’Connell. (2018) The US Military Commitment to Vaccine Development: A Century of Successes and Challenges. Frontiers in Immunology 9.
Crossref
Shauna Butler, Deena Sutter & Ashley Maranich. (2016) Tolerability of Japanese Encephalitis Vaccine in Pediatric Patients: Table 1.. Journal of the Pediatric Infectious Diseases Society, pages piw029.
Crossref
Ki Wook Yun, Hoan Jong Lee, Jin Han Kang, Byung Wook Eun, Yae-Jean Kim, Kyung-Hyo Kim, Nam Hee Kim, Young Jin Hong, Dong Ho Kim, Hwang Min Kim & Sung-Ho Cha. (2015) Safety and immunogenicity of a freeze-dried, Vero cell culture-derived, inactivated Japanese encephalitis vaccine (KD-287, ENCEVAC®) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children: a phase III, multicenter, double-blinded, randomized trial. BMC Infectious Diseases 15:1.
Crossref
Maria Paulke-Korinek, Herwig Kollaritsch, Michael Kundi, Ines Zwazl, Claudia Seidl-Friedrich & Tomas Jelinek. (2015) Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis. Vaccine 33:30, pages 3600-3604.
Crossref
Theodore C. Pierson & Michael S. Diamond. 2015. The Molecular Basis of Viral Infection. The Molecular Basis of Viral Infection 141 166 .
. 2015. Diagnostic Pathology: Infectious Diseases. Diagnostic Pathology: Infectious Diseases I-2-2 I-2-5 .
Martin Alberer, Gerd Burchard, Tomas Jelinek, Emil Reisinger, Jiri Beran, Seetha Meyer, Eduardo Forleo-Neto, Dieter Gniel, Alemnew F. Dagnew & Ashwani Kumar Arora. (2014) Co-administration of a meningococcal glycoconjugate ACWY vaccine with travel vaccines: A randomized, open-label, multi-center study. Travel Medicine and Infectious Disease 12:5, pages 485-493.
Crossref
Mikio Kimura, Tatsuya Fujii & Bernadette Carroll. (2014) Prioritising immunisations for travel: International and Japanese perspectives. Travel Medicine and Infectious Disease 12:2, pages 118-128.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.